The gene at the Duchenne/Becker muscular dystrophy locus encodes dystrophin, a member of a protein superfamily that links the actin cytoskeleton to transmembrane plasmalemmal proteins. In mature skeletal myocytes, the absence of dystrophin is associated with decreased membrane stability, altered kinetics of several calcium channels, and increased intracellular calcium concentration. In the central nervous system, dystrophin is restricted to specific neuronal populations that show heightened susceptibility to excitotoxic damage and is localized in proximal dendrites and the neuronal somata. We report that CAl pyramidal neurons in a hippocampal slice preparation from a dystrophin-deficient mouse genetic model of Duchenne muscular dystrophy (the mdx mouse) exhibit significant increased susceptibility to hypoxiainduced damage to synaptic transmission. This selective vulnerability was substantially ameliorated by pretreatment with diphenylhydantoin, an anticonvulsant that blocks both sodiumdependent action potentials and low-threshold transient calcium conductances. These rindings suggest that dystrophin deficiency could predispose susceptible neuronal populations to cumulative hypoxic insults that may contribute to the development of cognitive deficits in Duchenne/Becker muscular dystrophy patients and that the effects of such periods of hypoxia may be pharmacologically remediable.
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Duchenne muscular dystrophy (DMD) is a common, allelic, X chromosome-linked recessive neuromuscular disorder in which patients also exhibit significant cognitive and behavioral disabilities, including attention deficit disorders and infantile autism (1) (2) (3) . In skeletal muscle, dystrophin, the DMD gene product, is a component of a multiunit protein complex that links intrinsic sarcolemmal proteins to the actin-based cytoskeleton (4-6). Significant alterations in calcium channel physiology and elevated intracellular calcium concentrations have been demonstrated in DMD myocytes and in the mdx mouse strain, a dystrophin-deficient genetic mouse model (7) (8) (9) (10) . In the central nervous system (CNS), a distinct dystrophin mRNA is transcribed from a separate upstream promoter (11) (12) (13) , and the protein is confined to specific regions of neuronal somata and proximal dendrites (14) . This suggests that dystrophin may serve a regional modulatory role in relation to specific ligand receptors or ion channel subclasses.
Sustained increases in intracellular calcium concentrations have been proposed as a final common element in excitotoxic cascades leading to neuronal injury and death following periods of hypoxia or ischemia (15) . Pathological studies of brains of cognitively impaired DMD patients have shown reductions in brain weight, preferential loss of neuronal populations that normally express dystrophin, and small cortical ischemic infarcts (16) . In addition, DMD patients may be at increased risk for pathological periods of hypoxia during development because of the presence of a CNS vasculopathy (17) and profound sleep-associated episodes of arterial 02 desaturation (18, 19) . Therefore, we tested the hypothesis that absence of functional dystrophin may heighten the sensitivity of susceptible neuronal populations to hypoxia-induced neuronal injury, as assessed by the loss of synaptic transmission during hypoxia and the extent of recovery following reoxygenation.
As a CNS DMD model system, we utilized a hippocampal/ entorhinal cortex slice preparation from the mdx mouse, which has a point mutation within the dystrophin gene locus that causes premature chain termination (20) and absence of functional dystrophin in mature hippocampal and neocortical neurons (21) . Thus, pathological dystrophin transcripts encode a protein that lacks the normal C terminus and hence is unable to attach to the plasma membrane and is degraded in the cytoplasm. Early in human myotubular development, dystrophin is not attached to the external cellular membrane and shows no qualitative differences in tissue immunoreactivity from DMD or Becker muscular dystrophy patients, suggesting an underlying developmental disorder of membrane integration (22, 23) . Although mdx mice show histologic evidence of muscular dystrophy and late clinical signs of motor incoordination, no behavioral studies have yet addressed the issue of possible attention deficit or memory disorders associated with genetic deficiency of murine dystrophin (24) (25) (26) .
The hippocampal slice preparation with entorhinal cortex attached was used to retain intact entorhinal synaptic inputs to CA1 pyramidal neurons that can contribute to hypoxiainduced excitotoxicity (27) . We report here that, when hippocampal slices taken from mdx mice are subjected to brief periods of severe hypoxia, synaptic transmission in the CA1 region is markedly more sensitive to hypoxia-induced damage than transmission in slices from age-matched normal mice. These findings suggest that dystrophin plays an important role in protecting neurons from hypoxia-induced damage, perhaps by regulation of calcium channel distribution and/or permeability. trodes were used for stimulation (50-,um tip diameter). External bathing solution contained 126 mM NaCl, 5 mM KCl, 1.25 mM NaH2PO4, 2 mM MgCl2, 2 mM CaCl2, 26 mM NaHCO3, and 10 mM glucose. Slices were oxygenated by passing humidified 95% 02/5% CO2 over the upper surface of the slices, as well as by gassing the external solution prior to perfusion. Extracellular field potentials (excitatory postsynaptic potentials, EPSPs) were recorded in the CA1 pyramidal cell dendritic layer (stratum radiatum) and evoked by bipolar stimulation of Schaffer collateral/commissural axons in stratum radiatum.
MATERIALS AND METHODS
Induction of Hypoxia. Hypoxia was produced by gassing slices and media with 95% N2/5% CO2 to reduce Po2 markedly without altering pH buffering. Slices were made hypoxic for graded periods of 5-15 min and then were switched back to gassing with 95% 02/5% CO2. Recording chambers consisted of two wells, one for control and one for mdx slices, exposed to the same period of hypoxia in parallel. Throughout the experiment, synaptic transmission was monitored in each slice by simultaneous single stimulations applied once every 30 sec to each slice and equally matched to evoke half-maximal-amplitude EPSP recordings in stratum radiatum. Comparisons between groups were made using Student's t test for unpaired measures (two-tailed). Synaptic transmission was assessed by measuring the maximum slope of the initial EPSP uncontaminated by population actionpotential firings.
Pretreatment with Diphenyihydantoin (DPH). To test the protective actions of DPH, mdx slices from the same mouse were placed in both dual-compartment interface chambers and gassed simultaneously with N2/CO2. DPH (20 uM 30 min after a 5-min period of hypoxia is presented in Fig. 3 .
While control slices exhibited >90%o (93.6 ± 5.7%) recovery following hypoxia, the mdx slices averaged only 23.7 ± 8.6% recovery to the same hypoxic insults (P < 0.05, Student's t test). DPH Protects Against Hypoxia-Induced Loss of Synaptic Transmission in Control and mdx Hippocampal Slices. The anticonvulsant compound DPH (phenytoin) can protect hippocampal CA1 pyramidal neurons from hypoxia-induced damage (30) and reduce post-hypoxic learning deficits (31), while not blocking induction of long-term potentiation (30, 32) . Therefore, we evaluated the ability of a therapeutic concentration of DPH (20 AM), applied before and during a series of hypoxic insults, to protect against the loss of (Fig. 4) . A 5-min hypoxic insult to untreated mdx slices resulted in complete irreversible loss of evoked EPSPs 30 min following hypoxia (Fig. 4) . In contrast, simultaneous induction of hypoxia in DPH-treated mdx slices resulted in almost complete preservation of synaptic potentials recorded 30 min after a 5-min hypoxic period, and an 8-min period of hypoxia was required to cause irreversible damage (Fig. 4 ). An analysis of a typical experimental time profile from another set of slices is presented in Fig. 5 . The maximal initial slope of the Schaffer collateral/commissural evoked EPSP in area CA1 was measured throughout the experiment. Consecutive hypoxic episodes of 5, 8, and 12 min were applied (Fig. 5, bars) . In this experiment, untreated mdx slices displayed significant, but not complete, preservation of EPSP slope after 5 min of hypoxia but showed complete and irreversible loss of synaptic transmission following 8 min of hypoxia (open circles). In contrast, DPH-treated mdx slices exhibited complete preservation of EPSP slope after both 5 and 8 min of hypoxia, with complete loss of transmission requiring 12 min of hypoxia (closed circles). from hypoxia-induced damage. Schaffer collateral/commissural evoked potentials were recorded from an untreated mdx slice and a second slice from the same mouse, pretreated with DPH prior to hypoxia. DPH was bath-applied 30 min prior to the first hypoxic insult and was present throughout the remainder of the experiment. In the untreated mdx slice, the initial 5-min period of hypoxia completely and irreversibly eliminated synaptic transmission. In contrast, the DPH-treated slice completely recovered from 5 min of hypoxia when reoxygenated (traces shown after 30 min of 02), and was only irreversibly damaged by an 8-min hypoxic insult. Dots denote stimulus artifacts. 
DISCUSSION
This study demonstrates enhanced sensitivity of mdx hippocampal CAl pyramidal neurons to hypoxia-induced loss of synaptic transmission. Global ischemic models and human clinicopathological material suggest that CA1 pyramidal neurons are particularly vulnerable to hypoxia and ischemiainduced cell injury and death (33) (34) (35) and that these pathologic reactions are associated with marked memory deficits (32) that are prominent in DMD patients (1) (2) (3) . Individuals with DMD may be at increased risk for hypoxic and ischemic neuronal injury because they exhibit a CNS vasculopathy (17) and profound sleep-associated episodes of arterial oxygen desaturation (18, 19) . The enhanced neuronal loss may be cumulative and could contribute to the cognitive deficits that are associated with DMD patients. In addition, dystrophin appears to be restricted to specific neuronal populations (hippocampal pyramidal cells, cerebellar Purkinje cells, and deep-layer dorsolateral frontal large pyramidal neurons) that show heightened susceptibility to hypoxia and ischemia (14, 36) . The cognitive deficits in DMD patients are not global (1) (2) (3) but may disproportionally impair components of a distributed attentional network that presents clinically as attention deficit disorders and infantile autism (37) (38) (39) (40) (41) (42) . Deficits within these component subsystems, including the hippocampus, may cause alterations in selective and sustained attention and in verbal learning (37-39, 43, 44) . In fact, neuropathologic and physiologic neuroimaging studies of attention deficit disorders and infantile autism have demonstrated structural and metabolic alterations in neuroanatomic regions coincident with dystrophin expression (40) (41) (42) .
Elevated intracellular calcium levels as a consequence of increased membrane flux and release from intracellular stores may be a common mediator of irreversible cellular injury following a cascade of metabolic effects involving persistent neuronal depolarization, free radical formation, and lipid peroxidation of external cellular membranes (15) . In DMD and mdx myocytes, several studies have already demonstrated elevated intracellular calcium concentrations, even early in development, and physiologic alterations in multiple sarcolemmal calcium channels (7) (8) (9) . A similar observation has been presented for an analogous calcium channel in mdx cerebellar granule cells; however, this cell type has not been shown to express dystrophin (45) . One explanation for the enhanced sensitivity of mdx hippocampal pyramidal neurons to hypoxic insult may be generalized plasmalemmal instability (46) , analogous to the effects of dystrophin deficiency on mdx myocytes, resulting in enhanced influx of calcium and other ions, triggering the neuronal excitotoxic cascade. However, the subcellular localization of dystrophin in the CNS to discrete domains on the neuronal somata and proximal dendrites (14) suggests a more specific regional modulatory role for the protein, perhaps coupled to calcium or some other ion channels. A precedent for this suggestion is the association of ankyrin, a functionally related cytoskeletal "linker" protein, with a brain sodium channel of neuronal somata (47) . Blockers of high-threshold, voltage-dependent (L-type) calcium channels have been shown to improve associative learning in the rabbit nictitating-membrane conditioning model (48) and the retention of a simple associative learning paradigm in rats (49) . Studies using monoclonal antibodies to an epitope of the L-type calcium channel indicate that the subcellular localization of L-channels in hippocampal pyramidal neurons is virtually identical to dystrophin's (50) . This leads to the untested hypothesis that dystrophin may regulate the normal closure or voltage dependence of L-type calcium channels.
An additional experimental finding, potentially of considerable therapeutic importance, is our observation that pretreatment of mdx slices with a therapeutic concentration of the anticonvulsant DPH can substantially protect mdx hippocampal neurons from hypoxia-induced loss of synaptic transmission. DPH, at therapeutic concentrations, has been shown to dampen neuronal excitability, inhibit several calcium-dependent neuronal functions, block both highfrequency sodium-dependent action potentials and lowthreshold, transient calcium channel conductances, and protect against hypoxia-induced loss of synaptic function at Schaffer collateral synapses of CA1 hippocampal pyramidal neurons (30, 51, 52) . DPH may be but one of a number of therapeutic agents that could help prevent the neurodevelopmental and cognitive consequences of DMD or other human gene lesions by interrupting the underlying hypoxiainduced hyperactivation of signal transduction pathways. As future studies better define the integrated CNS roles of the dystrophin molecule and the functional consequences of its deficiency, it may be possible for the first time to directly correlate a precise neural molecular lesion with its specific physiological consequences regarding higher-order cognitive processing.
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